India’s molecular diagnostics market needs a change Delhi's Premas Life Sciences Pvt Ltd and US-based IncellDx Inc have signed an exclusive distribution agreement to bring the power of cell by cell multiplex diagnostics for solid tumors carcinomas that can now...
Read moreDetails

